New stent combo could rival standard heart treatment
NCT ID NCT07566091
First seen May 14, 2026 · Last updated May 23, 2026 · Updated 2 times
Summary
This study compares a new stent that releases sirolimus and ascorbic acid (vitamin C) to a standard everolimus stent in about 2,000 people with coronary artery disease who need a procedure to open blocked heart arteries. The goal is to see if the new stent is as good as the standard one at preventing heart-related problems like heart attack or the need for another procedure within one year. Participants will be randomly assigned to receive one of the two stents and will be followed for outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Asan Medical Center
Seoul, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.